Literature DB >> 1637568

Bone mass status in different degrees of chronic renal failure.

M L Bianchi1, G Colantonio, A Montesano, C Trevisan, S Ortolani, R Rossi, G Buccianti.   

Abstract

Bone mineral density (BMD) was evaluated in 69 patients with chronic renal failure (CRF) and in healthy controls matched for age, sex, and, for women, menopausal status. Both appendicular (predominantly cortical) and axial (predominantly trabecular) bone mass were measured. Appendicular BMD was measured by single photon absorptiometry on the distal forearm and axial BMD was measured by dual photon absorptiometry on the lumbar spine. Patients were divided into three groups on the basis of creatinine clearance: group 1, 58 to 36 ml/min; group 2, 30 to 18 ml/min; group 3, 15 to 9 ml/min. Both appendicular and axial BMD decreased with the worsening of renal failure. Parathyroid hormone levels were inversely correlated with the values of appendicular BMD. BMD values were significantly lower in postmenopausal than in premenopausal women. Months of menopause were inversely correlated with axial BMD values. Appendicular BMD was lower in CRF patients than in controls, and both appendicular and axial BMD were significantly lower in postmenopausal uremic women than in postmenopausal healthy women.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637568     DOI: 10.1016/8756-3282(92)90201-7

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

1.  Skeletal status in adolescents with end-stage renal failure: a longitudinal study.

Authors:  Wojciech Pluskiewicz; Piotr Adamczyk; Bogna Drozdzowska; Krystyna Szprynger; Maria Szczepańska; Zenon Halaba; Dariusz Karasek
Journal:  Osteoporos Int       Date:  2004-06-25       Impact factor: 4.507

2.  Bone mineral density in children with chronic renal failure.

Authors:  Simon Waller; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2006-09-15       Impact factor: 3.714

3.  Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease.

Authors:  S Geng; Z Kuang; P L Peissig; D Page; L Maursetter; K E Hansen
Journal:  Osteoporos Int       Date:  2019-05-31       Impact factor: 4.507

4.  Comparative study of quantitative ultrasonography and dual-energy X-ray absorptiometry for evaluating renal osteodystrophy in children with chronic kidney disease.

Authors:  Athanasios Christoforidis; Nikoleta Printza; Chrysa Gkogka; Ekaterini Siomou; Anna Challa; Eirini Kazantzidou; Konstantinos Kollios; Fotis Papachristou
Journal:  J Bone Miner Metab       Date:  2010-09-16       Impact factor: 2.626

5.  Bone density measurements in pediatric patients with renal osteodystrophy.

Authors:  Eleonora M Lima; William G Goodman; Beatriz D Kuizon; Barbara Gales; Aletha Emerick; Jonathan Goldin; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2003-04-24       Impact factor: 3.714

6.  Skeletal status in children and adolescents with chronic renal failure before onset of dialysis or on dialysis.

Authors:  W Pluskiewicz; P Adamczyk; B Drozdzowska; K Szprynger; M Szczepańska; Z Halaba; D Karasek
Journal:  Osteoporos Int       Date:  2003-04-16       Impact factor: 4.507

7.  Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients.

Authors:  Konstantinos K Doumouchtsis; Alkis I Kostakis; Stergios K Doumouchtsis; Marios P Tziamalis; Charalambos P Stathakis; Evanthia Diamanti-Kandarakis; Dimitrios Dimitroulis; Despoina N Perrea
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

8.  The effect of raloxifene treatment in postmenopausal women with CKD.

Authors:  Areef Ishani; Terri Blackwell; Sophie A Jamal; Steven R Cummings; Kristine E Ensrud
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

9.  Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study.

Authors:  A Ishani; M Paudel; B C Taylor; E Barrett-Connor; S Jamal; M Canales; M Steffes; H A Fink; E Orwoll; S R Cummings; K E Ensrud
Journal:  Osteoporos Int       Date:  2008-04-05       Impact factor: 4.507

10.  Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.

Authors:  H McKee; G Ioannidis; A Lau; D Treleaven; A Gangji; C Ribic; M Wong-Pack; A Papaioannou; J D Adachi
Journal:  Osteoporos Int       Date:  2020-01-03       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.